Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: original reference not translated (Russian)

Data source

Reference
Title:
No information
Author:
Burlaka-Vovk, Z.I. et al.: in Endocrine system and toxic|environmental factors. Leningrad; 1979: 19-24: cited in|Chlorobenzenes (Series "Scientific Reviews of Soviet Lit-|erature of Toxicity and Hazards of Chemicals"), edited by |Izmerov, N.F., Centre for International Projects, GKNT, |Moscow, 1988; data compiled by Vasilenko, N.M. and Semilet-|kina, N.N. (number of issue: 108)

Materials and methods

GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
1,2-dichlorobenzene
EC Number:
202-425-9
EC Name:
1,2-dichlorobenzene
Cas Number:
95-50-1
Molecular formula:
C6H4Cl2
IUPAC Name:
1,2-dichlorobenzene

Test animals

Species:
rabbit
Strain:
not specified
Sex:
not specified

Administration / exposure

Route of administration:
inhalation
Duration of treatment / exposure:
7-8 months
Frequency of treatment:
4 h/d, 5 d/w
Doses / concentrations
Remarks:
Doses / Concentrations:
0.05 mg/l
Basis:

Control animals:
yes
Details on study design:
Post-exposure period: no data

Results and discussion

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

Effects on adrenal cortex function: short increase in the blood plasma level of 11-oxycorticosteroids at 3 and 5 months of exposure.

Applicant's summary and conclusion